The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 08, 2006
Filed:
Mar. 16, 2005
Daniel Jon Sall, Greenwood, IN (US);
Jolie Anne Bastian, Beech Grove, IN (US);
Cynthia Darshini Jesudason, Indianapolis, IN (US);
Don Richard Finley, Greenwood, IN (US);
Freddie Craig Stevens, Indianapolis, IN (US);
Vincent Patrick Rocco, Indianapolis, IN (US);
Patrick Gianpietro Spinazze, Avon, IN (US);
John Xiaoqiang He, Fishers, IN (US);
John Arnold Werner, Indianapolis, IN (US);
William George Trankle, Souhtport, IN (US);
Andrew Michael Ratz, Indianapolis, IN (US);
Theo Schotten, Vierhufen, DE;
Gerd Reuhter, Hamburg, DE;
Daniel Jon Sall, Greenwood, IN (US);
Jolie Anne Bastian, Beech Grove, IN (US);
Cynthia Darshini Jesudason, Indianapolis, IN (US);
Don Richard Finley, Greenwood, IN (US);
Freddie Craig Stevens, Indianapolis, IN (US);
Vincent Patrick Rocco, Indianapolis, IN (US);
Patrick Gianpietro Spinazze, Avon, IN (US);
John Xiaoqiang He, Fishers, IN (US);
John Arnold Werner, Indianapolis, IN (US);
William George Trankle, Souhtport, IN (US);
Andrew Michael Ratz, Indianapolis, IN (US);
Theo Schotten, Vierhufen, DE;
Gerd Reuhter, Hamburg, DE;
Eli Lilly and Company, Indianapolis, IN (US);
Abstract
The present invention relates to a β3 adrenergic receptor agonist of formula I: or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.